Location: United States, Washington, Seattle
Employees: 1-10
Total raised: $76.1M
Founded date: 2018
Investors 1
Funding Rounds 2
| Date | Series | Amount | Investors |
| 26.06.2023 | Series B | $53M | - |
| 14.01.2021 | Series A | $23.1M | - |
Mentions in press and media 10
| Date | Title | Description |
| 26.06.2023 | AltPep Closes $53M Series B Financing | AltPep, a Seattle, WA-based biotechnology company, raised $53M in Series B funding. The round was led by Senator Investment Group, with participation from new financial investors Section 32, Partners Investment, and Eli Lilly and Company. I... |
| 22.06.2023 | AltPep Closes $52.9M Series B Round | SEATTLE, WA, AltPep today announced the completion of a $52.9 million Series B financing round. >> Click here for more funding data on AltPep >> To export AltPep funding data to PDF and Excel, click here AltPep, a private... |
| 19.05.2023 | GeekWire Awards 2023 revealed: Community honors top innovation in Pacific Northwest tech | Jake Stallman, VP of build quality and design at Carbon Robotics, snags a selfie with R2-D2 while accepting the Hardware/Gadget/Robotics of the Year Award at the 2023 GeekWire Awards. (GeekWire Photo / Kevin Lisota) A Star Wars theme comple... |
| 18.04.2023 | Protein design to precision health: Vote for Health Innovation of the Year at the GeekWire Awards | Finalists for the 2023 GeekWire Health Innovation of the Year. This year’s nominees for the Health Innovation of the Year at the GeekWire Awards showcase a wide range of innovations from companies focused on diagnostics, therapeutics, digit... |
| 29.09.2022 | Promising data from large Alzheimer’s study bodes well for this Seattle startup | AltPep CEO and founder Valerie Daggett. (AltPep Photo) Alzheimer’s disease researchers were buoyed by positive data released Tuesday from a large clinical trial of an experimental therapy being developed by Biogen and Eisai. The early data ... |
| 22.08.2022 | Seattle startup aiming to detect, treat Alzheimer’s and Parkinson’s disease raises cash | AltPep CEO and founder Valerie Daggett. (AltPep Photo) The news: University of Washington spinout AltPep recently raised $44.4 million, according to a regulatory filing. The company declined to discuss the filing, but founder and CEO Valeri... |
| 15.01.2021 | AltPep Raises $23M in Series A | SEATTLE, WA, AltPep announced it closed a $23.150 million Series A investment round led by Matrix Capital. >> Click here for more funding data on AltPep >> To export AltPep funding data to PDF and Excel, click here AltPep... |
| 14.01.2021 | AltPep Raises $23M Jumpstarting Work on Alzheimer's Disease | |
| 14.01.2021 | Seattle biotech startup AltPep raises $23.1M to tackle Alzheimer’s and related diseases | Valerie Daggett, founder and CEO of AltPep. (UW Photo) AltPep, a Seattle-based biotech startup tackling amyloid protein disorders, has raised $23.1 million in a Series A funding round. The venture spun out the University of Washington in Ma... |
| - | AltPep | “parkinson's disease, Parkinson's disease, Alzheimer's disease, alzheimer's disease, alzheimer's, diagnosis, therapeutics, amyloid, oligomers, peptide, peptides” |